In this issue:
Response to biologic drugs and antidrug antibodies in RA
Secukinumab for giant cell arteritis
Treatment of immune checkpoint inhibitor-associated arthritis
Rituximab in AAV and relapsing disease
Mepolizumab for eosinophilic granulomatosis with polyangiitis
Adherence to colchicine prophylaxis in patients with familial Mediterranean fever
Functional polymorphisms and responsiveness to biologics
bDMARDs as induction therapy in early and severe RA
Rituximab resistance in AAV
Please login below to download this issue (PDF)